(341 days)
Not Found
No
The description mentions "internal software is used for error checking and calibration" and "statistical analysis is performed to ensure repeatability," but these are standard computational tasks and do not indicate the use of AI or ML. There is no mention of AI, ML, or related terms like neural networks or deep learning.
No.
The device measures intraocular pressure and ocular pulsatile amplitude, which are diagnostic measurements, not therapeutic interventions.
Yes
The device is indicated for the measurement of intraocular pressure and ocular pulsatile amplitude, which are used to diagnose conditions related to eye health.
No
The device description clearly outlines physical components like a disposable sterile plastic prism, a free-floating counterweighted arm, and the use of visible light and total internal reflectance, indicating it is a hardware device with internal software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Function: The Falck Medical Applanation Tonometer Model 2 directly measures intraocular pressure and ocular pulsatile amplitude by interacting with the cornea of the eye. It does not analyze a specimen taken from the body.
Therefore, based on the provided information, the device is a medical device used for direct measurement on a patient, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Falck Medical Applanation Tonometer (FAT 2) is indicated in the measurement of intraocular pressure and ocular pulsatile amplitude.
Product codes (comma separated list FDA assigned to the subject device)
HKY, HKX
HKY, HPK, NJJ
Device Description
The Falck Medical Applanation Tonometer (FAT 2) measures the intraocular pressure by applanation of the cornea uses a disposable sterile plastic prism. It is used as an accessory to a slit lamp microscope. Internal software is used for error checking and calibration. The disposable prism is mounted on a free floating counterweighted arm. When the prism comes into contact with the cornea, the initial applanation area is determined by the biomechanics of the cornea. Force is then actively applied to the cornea and measurements are taken every 13.8 milliseconds. Multiple readings are taken and statistical analysis is performed to ensure repeatability. The measurement principle is the same as the Goldmann, but adjustments are reade for variations in surface wetness and corneal resistance. The size of the applanation area is objectively determined by using visible light and the principle of total internal reflectance (TIR).
A new sterile disposable prism is required prior to each new patient. In addition to intraocular pressure, the device also measures ocular pulsatile amplitude by recording the change in the applanation signal that occurs with the cardiac cycle. The measurement of ocular pulsatile amplitude is similar to the Langham methodology.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cornea
ocular
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained Assistant
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility and Toxicity Testing: Biocompatibility testing was performed on the prism material to establish a safety profile for the device. Toxicity testing included cytotoxicity, ocular irritation, and systemic toxicity. All testing was found to be non-toxic to ocular and systemic tissues.
Manometric Study Summary: In a comparative study of Falck Applanation Tonometer readings to a reference u-tube mercury manometer using human eye bank eyes, the following results were obtained:
- Average Coefficient of Variation: 2.6% +/- 0.10 (5 to 50mmHg).
- Average Standard Deviation: 0.7 mmHg +/- 0.4, range 0.09 1.26, (5 to 50mmHg).
Clinical Trial Summary: In a clinical trial comparing the Falck Applanation Tonometer to a reference Goldmann applanation tonometer for IOP measurement in 205 eyes, the following results were obtained:
- Average Mean Difference between Falck Applanation Tonometer and the Goldmann Applanation Tonometer: 0.7mmHg, SD=2.0, r2= 0.93, (9 to 56mmHg).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Average Coefficient of Variation: 2.6% +/- 0.10 (5 to 50mmHg).
Average Standard Deviation: 0.7 mmHg +/- 0.4, range 0.09 1.26, (5 to 50mmHg).
Average Mean Difference between Falck Applanation Tonometer and the Goldmann Applanation Tonometer: 0.7mmHg, SD=2.0, r2= 0.93, (9 to 56mmHg).
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.1930 Tonometer and accessories.
(a)
Identification. A tonometer and accessories is a manual device intended to measure intraocular pressure by applying a known force on the globe of the eye and measuring the amount of indentation produced (Schiotz type) or to measure intraocular tension by applanation (applying a small flat disk to the cornea). Accessories for the device may include a tonometer calibrator or a tonograph recording system. The device is intended for use in the diagnosis of glaucoma.(b)
Classification. Class II.
0
K07/755
510(k) SUMMARY
JUN - 3 2008
| 1. | Submitter Information: | ||
|---|---|---|---|
| A. | Company Name/Address: | Falck Medical, Inc. | |
| 35 Washington Street, Suite 2 | |||
| Mystic, CT 06355 | |||
| (860) 536-9000 | |||
| (860) 536-9000 FAX | |||
| B. | Contact Person: | Francis Falck, Jr., M.D., PhD, M.S. | |
| CEO and President | |||
| C. | Manufacturing Location: | To be determined | |
| 2. | Device Information: | ||
| A. | Device Trade Name: | Falck Medical Applanation Tonometer (FAT 2) | |
| B. | Classification Name: | tonometer | |
| C. | Classification Panel: | 86: ophthalmic | |
| D. | Device Classification Number: | 886.1930 | |
| E. | Product Codes: | HKY, HKX | |
| 3. | Substantial Equivalence: |
The Falck Applanation Tonometer Model 2 (FAT 2) is substantially equivalent to the Goldmann Applanation Tonometer SL 900, (K981432). The device is based on the Imbert -Fick Law and uses applanation of the cornea to measure the intraocular pressure.
Additionally, the FAT 2 is substantially equivalent to the Langham Model 201 Tonograph/Tonometer (K010998) for the measurement of ocular pulsatile amplitude.
The list of equivalent devices follows:
| K981432 | 1/12/1999 | Goldmann Tonometer | Golden Vision, Inc. |
|---|---|---|---|
| K010998 | 6/27/2001 | Model 201 Tonograph/Tonometer | Langham Ophthalmic |
| Technologies |
Intended use: ধা
ന്
The Falck Medical Applanation Tonometer (FAT 2) is indicated in the measurement of intraocular pressure and ocular pulsatile amplitude.
Device Description: ട്.
The Falck Medical Applanation Tonometer (FAT 2) measures the intraocular pressure by applanation of the cornea uses a disposable sterile plastic prism. It is used as an accessory to a slit lamp microscope. Internal software is used for error checking and calibration. The disposable prism is mounted on a free floating counterweighted arm. When the prism comes into contact with the cornea, the initial applanation area is determined by the biomechanics of the cornea. Force is then actively applied to the cornea and measurements are taken every 13.8 milliseconds. Multiple readings are taken and statistical analysis is performed to ensure repeatability. The measurement principle is the same as the Goldmann, but adjustments are reade for variations in surface wetness and corneal resistance. The size of the applanation
1
area is objectively determined by using visible light and the principle of total internal reflectance (TIR).
A new sterile disposable prism is required prior to each new patient. In addition to intraocular pressure, the device also measures ocular pulsatile amplitude by recording the change in the applanation signal that occurs with the cardiac cycle. The measurement of ocular pulsatile amplitude is similar to the Langham methodology.
Performance Testing റ്.
Biocompatibility and Toxicity Testing
The disposable prism is designed to come into contact with the cornea for a short period of time. Biocompatibility testing was performed on the prism material to establish a safety profile for the device. Toxicity testing included cytotoxicity, ocular irritation, and systemic toxicity. All testing was found to be non-toxic to ocular and systemic tissues.
Manometric Study Summary
In a comparative study of Falck Applanation Tonometer readings to a reference u-tube mercury manometer using human eye bank eyes, the following results were obtained:
- Average Coefficient of Variation: 2.6% +/- 0.10 (5 to 50mmHg). .
- Average Standard Deviation: 0.7 mmHg +/- 0.4, range 0.09 1.26, (5 to 50mmHg). .
Clinical Trial Summary
In a clinical trial comparing the Falck Applanation Tonometer to a reference Goldmann applanation tonometer for IOP measurement in 205 eyes, the following results were obtained:
- Average Mean Difference between Falck Applanation Tonometer and the Goldmann ◆ Applanation Tonometer: 0.7mmHg, SD=2.0, r2= 0.93, (9 to 56mmHg).
2
| Function | Falck
(FAT 2)
Subject of
510(k) | Goldmann SL
900 Tonometer
K981432 | Langham Ocular
Blood Flow (OBF)
Tonograph-
Tonometer
K010998 |
|--------------------------------------------------|------------------------------------------|-----------------------------------------|--------------------------------------------------------------------------|
| Measurement independent
of corneal resistance | Yes | No | No |
| Topical anesthetic use | Yes | Yes | Yes |
| Fluorescein use required | No | Yes | No |
| Measures ocular pulse | Yes | No | Yes |
| Ocular Pulsatile Amplitude | Yes | No | Yes |
| Patient position during test | Sitting only | Sitting only | Sitting / Supine |
| Force application of
tonometer arm | Automatic | Manual | Pneumatic |
| Skill level required | Trained
Assistant | Trained
Assistant | Trained
Assistant |
| Requires slit lamp | Yes | Yes | No |
| Sampling Frequency | 145 samples
per second | 60 seconds | 100 samples
per second |
| Electronic | Yes | No | Yes |
| Data capture | Yes | No | Yes |
| Data communication | Yes | No | No |
7. Device Comparisons (Similarities and Differences) to Predicate Devices
:
:
:
3
Image /page/3/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with its wings spread, symbolizing protection and care. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The seal is presented in black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN - 3 : 2008
Falck Medical, Inc c/o Richard E. Lippman O.D., F.A.A.O. VP Ophthalmic Product Regulatory Affairs R.P. Chiacchierini & Associates, LLC 15825 Shady Grove Rd., Suite 30 Rockville, MD 20850
Re: K071755
Trade Name: Falck Applanation Tonometer (FAT 2) Regulation Number: 21 CFR 886.1930 Regulation Name: Tonometer and accessories Regulatory Class: Class II Product Code: HKY, HPK, NJJ Dated: May 19, 2008 Received: May 19, 2008
Dear Dr. Lippman:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Malvina B. Reynolds, and
Malvina B. Eydelman, M.D Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K071755
Device Name: Falck Medical Applanation Tonometer Model 2 (FAT 2)
Indications for Use:
The Falck Medical Applanation Tonometer Model 2 (FAT 2) is indicated in the measurement of intraocular pressure and ocular pulsatile amplitude.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use ( 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Dacoulus 5/30/2008
(Division Sign-Off) Division of Ophthalmic Ear, Nose and Throat Devises
Page 1 of
510(k) Number K071755